Comparative in vitro susceptibility of a tetracycline-resistant chlamydia trachomatis strain isolated in Toulouse (France)

Sexually Transmitted Diseases

Volumn 25, Issue 7, 1998, Pages 350-352

  Lefèvre, Jean Claude ^a,b   Lépargneur, Jean Pierre ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; ERYTHROMYCIN; OFLOXACIN; PRISTINAMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; FRANCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; STRAIN DIFFERENCE;

CHLAMYDIA TRACHOMATIS; FEMALE; FRANCE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; TETRACYCLINE RESISTANCE;

EID: 0344404207     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199808000-00005     Document Type: Article

References (14)

1. Piot P, Islam MQ. Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control. Sex Transm Dis 1994; 21:S7-S13.
2. Todd Weber J, Johnson RE. New treatments for Chlamydia trachomatis genital infection. Clin Infect Dis 1995; 20(suppl 1)S66-S71.
3. Ridgway GL. Treatment of chlamydial genital infection. J Antimicrob Chemother 1997; 40:311-314.
4. Lefèvre JC, Lépargneur JP, Guion D, Bei S. Tetracycline-resistant Chlamydia Trachomatis in Toulouse, France. Pathol Biol (Paris) 1997; 45:376-378.
5. Lefèvre JC, Bauriaud R. Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens. Antimicrob Agents Chemother 1989; 26:2152-2154.
6. Ehret JM, Judson FN. Susceptibility testing of Chlamydia trachomatis from eggs to monoclonal antibodies. Antimicrob Agents Chemother 1988; 32:1295-1299.
7. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 1997. Pathol Biol (Paris) 1997; 45:I-XII.
8. Ryffel C, Strässle A, Kayser FH, Berger-Bachi B. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994; 38:724-728.
9. Mourad A, Sweet RL, Sugg W, Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother 1980; 18:696-698.
10. Jones RB, Van der Pol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 1990; 162:1309-1315.
11. Jones RB, Van der Pol B, Batteiger BF. Prevalence of heterotypic tetracycline resistance among isolates of C. trachomatis from selected populations (Abstract 679). In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1990:199.
12. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydia: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58:686-699.
13. Munday PE, Thomas BJ, Gilroy CB, Gilchrist C, Taylor-Robinson D. Infrequent detection of Chlamydia trachomatis in a longitudinal study of women with treated cervical infection. Genitourin Med 1995;71:24-26.
14. Patton DL, Askienazy-Elbhar M, Henry-Suchet J, et al. Detection of Chlamydia trachomatis in fallopian tube tissue in women with post infectious tubal infertility. Am J Obstet Gynecol 1994; 171:95-101.